Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Deficit
Balance, shares at Dec. 31, 2017   11,906,783          
Balance, beginning of period at Dec. 31, 2017   $ 80,397          
Balance, beginning of period at Dec. 31, 2017     $ 1   $ 54,892   $ (144,804)
Balance, shares at Dec. 31, 2017     1,027,113        
Exercise of stock options         12    
Exercise of stock options, shares     9,977        
Exercise of warrants   $ 47          
Exercise of warrants, shares   310,676          
Employee and nonemployee stock-based compensation         129    
Reclassification of warrants from liability to preferred stock upon exercise   $ 2,951          
Net income (loss) $ (3,060)           (3,060)
Balance, shares at Sep. 30, 2018   12,217,459          
Balance, at end of period at Sep. 30, 2018   $ 83,395          
Balance, at end of period at Sep. 30, 2018 (92,830)   $ 1   55,033   (147,864)
Balance, shares at Sep. 30, 2018     1,037,090        
Balance, shares at Dec. 31, 2017   11,906,783          
Balance, beginning of period at Dec. 31, 2017   $ 80,397          
Balance, beginning of period at Dec. 31, 2017     $ 1   54,892   (144,804)
Balance, shares at Dec. 31, 2017     1,027,113        
Balance, at end of period at Dec. 31, 2018 5,129   $ 15   148,641   (143,527)
Balance, shares at Dec. 31, 2018     15,591,357        
Balance, shares at Jun. 30, 2018   11,906,783          
Balance, beginning of period at Jun. 30, 2018   $ 80,397          
Balance, beginning of period at Jun. 30, 2018     $ 1   54,969   (149,998)
Balance, shares at Jun. 30, 2018     1,037,090        
Exercise of stock options         1    
Exercise of warrants   $ 47          
Exercise of warrants, shares   310,676          
Employee and nonemployee stock-based compensation         63    
Reclassification of warrants from liability to preferred stock upon exercise   $ 2,951          
Net income (loss) 2,134           2,134
Balance, shares at Sep. 30, 2018   12,217,459          
Balance, at end of period at Sep. 30, 2018   $ 83,395          
Balance, at end of period at Sep. 30, 2018 (92,830)   $ 1   55,033   (147,864)
Balance, shares at Sep. 30, 2018     1,037,090        
Balance, beginning of period at Dec. 31, 2018 $ 5,129   $ 15   148,641   (143,527)
Balance, shares at Dec. 31, 2018     15,591,357        
Issuance of common stock, net of issuance costs     $ 1 $ 4 1,603 $ 36,845  
Issuance of common stock, net of issuance costs, shares     227,628 4,297,901      
Taxes paid on net issuance of restricted stock award         (1,897)    
Exercise of stock options         69    
Exercise of stock options, shares 85,559   85,559        
Exercise of warrants         23    
Exercise of warrants, shares     155,338        
Employee and nonemployee stock-based compensation         5,911    
Net income (loss) $ (19,057)           (19,057)
Balance, at end of period at Sep. 30, 2019 28,631   $ 20   191,195   (162,584)
Balance, shares at Sep. 30, 2019     20,357,783        
Balance, beginning of period at Jun. 30, 2019     $ 20   190,874   (155,816)
Balance, shares at Jun. 30, 2019     20,344,258        
Exercise of stock options         14    
Exercise of stock options, shares     13,525        
Employee and nonemployee stock-based compensation         307    
Net income (loss) (6,768)           (6,768)
Balance, at end of period at Sep. 30, 2019 $ 28,631   $ 20   $ 191,195   $ (162,584)
Balance, shares at Sep. 30, 2019     20,357,783